<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01966796</url>
  </required_header>
  <id_info>
    <org_study_id>102013-E</org_study_id>
    <nct_id>NCT01966796</nct_id>
  </id_info>
  <brief_title>Clinical Characteristics and Microbiology of Healthcare Associated Pneumonia</brief_title>
  <official_title>Clinical Characteristics and Microbiology of Healthcare Associated Pneumonia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Far Eastern Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Far Eastern Memorial Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background The prediction of multi-drug resistant (MDR) pathogens is a key issue in the&#xD;
      management of health-care associated pneumonia (HCAP). Multiple risk factors have been&#xD;
      proposed, some of which overlap with items of the pneumonia severity index (PSI). The aim of&#xD;
      this study was to investigate the relationship between PSI and presence of MDR pathogens.&#xD;
&#xD;
      Methods Patients who were admitted to a tertiary-care hospital from January 2005 to December&#xD;
      2010 were screened by a discharge diagnosis of pneumonia. Patients were enrolled if they&#xD;
      fulfilled the definition of HCAP by 2005 ATS/IDSA guideline.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      MDR bacteria were defined as Pseudomonas aeruginosa (P. aeruginosa), Enterobacter species,&#xD;
      those not sensitive to second and third generation cephalosporins, Acinetobacter species,&#xD;
      extended-spectrum β-lactamase (ESBL) Enterobacteriaceae such as Escherichia coli (E. coli)&#xD;
      and Klebsiella pneumoniae (K. pneumoniae), Burkholderia cepacia (B. cepacia),&#xD;
      Stenotrophomonas maltophilia (S. maltophilia), and methicillin resistant Staphylococcus&#xD;
      aureus (MRSA).&#xD;
&#xD;
      The criteria for HCAP is defined as follows: patients who had been hospitalized in an acute&#xD;
      care hospital for two or more days within the past 90 days; residents of a nursing home or&#xD;
      long-term care facility; recipients of recent intravenous antibiotic therapy, chemotherapy or&#xD;
      wound care within the past 30 days; or patients who attended a hospital or hemodialysis&#xD;
      clinic.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Pathogens of Healthcare Associated Pneumonia, Measured by the Number of Participants</measure>
    <time_frame>7 days</time_frame>
    <description>sputum culture and sterile specimen such as blood or pleural effusion culture for healthcare associated pneumonia within seven days of admission</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With MDR Pathogens</measure>
    <time_frame>seven days after admission</time_frame>
    <description>MDR bacteria were defined as Pseudomonas aeruginosa (P. aeruginosa), Enterobacter species, those not sensitive to second and third generation cephalosporins, Acinetobacter species, extended-spectrum β-lactamase (ESBL) Enterobacteriaceae such as Escherichia coli (E. coli) and Klebsiella pneumoniae (K. pneumoniae), Burkholderia cepacia (B. cepacia), Stenotrophomonas maltophilia (S. maltophilia), and methicillin resistant Staphylococcus aureus (MRSA).</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">530</enrollment>
  <condition>Healthcare Associated Pneumonia</condition>
  <arm_group>
    <arm_group_label>PSI II</arm_group_label>
    <description>PSI less than 70 or equal to 70</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PSI III</arm_group_label>
    <description>PSI 70-90</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PSI IV</arm_group_label>
    <description>PSI 90-130</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PSI V</arm_group_label>
    <description>PSI more than 130</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who were admitted to the Far Eastern Memorial Hospital, an 800-bed tertiary care&#xD;
        hospital in northern Taiwan, from January 2005 to December 2010 were screened by discharge&#xD;
        diagnoses.The patients whose primary discharge diagnosis was pneumonia (International&#xD;
        Classification of Diseases codes 482, 485, and 486) were selected.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients who had been hospitalized in an acute care hospital for two or more days&#xD;
             within the past 90 days;&#xD;
&#xD;
          -  residents of a nursing home or long-term care facility;&#xD;
&#xD;
          -  recipients of recent intravenous antibiotic therapy, chemotherapy or wound care within&#xD;
             the past 30 days;&#xD;
&#xD;
          -  or patients who attended a hospital or hemodialysis clinic.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ping-huai Wang, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Far Eastern Memorial Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Far Eastern Memorial Hospital</name>
      <address>
        <city>New Taipei</city>
        <zip>220</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <reference>
    <citation>Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis. 2000 Aug;31(2):347-82. Epub 2000 Sep 7.</citation>
    <PMID>10987697</PMID>
  </reference>
  <reference>
    <citation>Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995. Am J Respir Crit Care Med. 1996 May;153(5):1711-25. Review.</citation>
    <PMID>8630626</PMID>
  </reference>
  <reference>
    <citation>American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005 Feb 15;171(4):388-416.</citation>
    <PMID>15699079</PMID>
  </reference>
  <reference>
    <citation>Micek ST, Reichley RM, Kollef MH. Health care-associated pneumonia (HCAP): empiric antibiotics targeting methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa predict optimal outcome. Medicine (Baltimore). 2011 Nov;90(6):390-395. doi: 10.1097/MD.0b013e318239cf0a.</citation>
    <PMID>22033455</PMID>
  </reference>
  <reference>
    <citation>Song JH, Oh WS, Kang CI, Chung DR, Peck KR, Ko KS, Yeom JS, Kim CK, Kim SW, Chang HH, Kim YS, Jung SI, Tong Z, Wang Q, Huang SG, Liu JW, Lalitha MK, Tan BH, Van PH, Carlos CC, So T; Asian Network for Surveillance of Resistant Pathogens Study Group. Epidemiology and clinical outcomes of community-acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant pathogens. Int J Antimicrob Agents. 2008 Feb;31(2):107-14. Epub 2007 Dec 26.</citation>
    <PMID>18162378</PMID>
  </reference>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>October 12, 2013</study_first_submitted>
  <study_first_submitted_qc>October 17, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 22, 2013</study_first_posted>
  <results_first_submitted>October 24, 2013</results_first_submitted>
  <results_first_submitted_qc>September 7, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 9, 2020</results_first_posted>
  <last_update_submitted>September 7, 2020</last_update_submitted>
  <last_update_submitted_qc>September 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Far Eastern Memorial Hospital</investigator_affiliation>
    <investigator_full_name>Ping-Huai Wang</investigator_full_name>
    <investigator_title>Medical Dr</investigator_title>
  </responsible_party>
  <keyword>healthcare associated pneumonia</keyword>
  <keyword>drug-resistant bacteria</keyword>
  <keyword>pneumonia severity index</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Healthcare-Associated Pneumonia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients who were admitted to our hospital,Jan 2005 to Dec 2010 The patients with the diagnosis was pneumonia were selected. They were enrolled if they fulfilled the criteria for HCAP defined in 2005 ATS/IDSA</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>PSI II</title>
          <description>Pneumonia severity index less than 70 or equal to 70, (Pneumonia is more severe if the index is higher)</description>
        </group>
        <group group_id="P2">
          <title>PSI III</title>
          <description>Pneumonia severity index 70-90</description>
        </group>
        <group group_id="P3">
          <title>PSI IV</title>
          <description>Pneumonia severity index 91-130</description>
        </group>
        <group group_id="P4">
          <title>PSI V</title>
          <description>Pneumonia severity index more than 130</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="51"/>
                <participants group_id="P3" count="195"/>
                <participants group_id="P4" count="269"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="51"/>
                <participants group_id="P3" count="195"/>
                <participants group_id="P4" count="269"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>PSI II</title>
          <description>PSI less than 70 or equal to 70</description>
        </group>
        <group group_id="B2">
          <title>PSI III</title>
          <description>PSI 70-90</description>
        </group>
        <group group_id="B3">
          <title>PSI IV</title>
          <description>PSI 90-130</description>
        </group>
        <group group_id="B4">
          <title>PSI V</title>
          <description>PSI more than 130</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
            <count group_id="B2" value="51"/>
            <count group_id="B3" value="195"/>
            <count group_id="B4" value="269"/>
            <count group_id="B5" value="530"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="50"/>
                    <measurement group_id="B4" value="17"/>
                    <measurement group_id="B5" value="100"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="145"/>
                    <measurement group_id="B4" value="252"/>
                    <measurement group_id="B5" value="430"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49.7" spread="12.5"/>
                    <measurement group_id="B2" value="66.4" spread="11.7"/>
                    <measurement group_id="B3" value="73.3" spread="12.5"/>
                    <measurement group_id="B4" value="79.5" spread="10.2"/>
                    <measurement group_id="B5" value="75.1" spread="12.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="56"/>
                    <measurement group_id="B4" value="100"/>
                    <measurement group_id="B5" value="181"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="139"/>
                    <measurement group_id="B4" value="169"/>
                    <measurement group_id="B5" value="349"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Taiwan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="51"/>
                    <measurement group_id="B3" value="195"/>
                    <measurement group_id="B4" value="269"/>
                    <measurement group_id="B5" value="530"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Pathogens of Healthcare Associated Pneumonia, Measured by the Number of Participants</title>
        <description>sputum culture and sterile specimen such as blood or pleural effusion culture for healthcare associated pneumonia within seven days of admission</description>
        <time_frame>7 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PSI II</title>
            <description>Pneumonia severity index less than 70 or equal to 70, (Pneumonia is more severe if the index is higher)</description>
          </group>
          <group group_id="O2">
            <title>PSI III</title>
            <description>Pneumonia severity index 70-90</description>
          </group>
          <group group_id="O3">
            <title>PSI IV</title>
            <description>Pneumonia severity index 91-130</description>
          </group>
          <group group_id="O4">
            <title>PSI V</title>
            <description>Pneumonia severity index more than 130</description>
          </group>
        </group_list>
        <measure>
          <title>Pathogens of Healthcare Associated Pneumonia, Measured by the Number of Participants</title>
          <description>sputum culture and sterile specimen such as blood or pleural effusion culture for healthcare associated pneumonia within seven days of admission</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="51"/>
                <count group_id="O3" value="195"/>
                <count group_id="O4" value="269"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="51"/>
                    <measurement group_id="O3" value="195"/>
                    <measurement group_id="O4" value="269"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With MDR Pathogens</title>
        <description>MDR bacteria were defined as Pseudomonas aeruginosa (P. aeruginosa), Enterobacter species, those not sensitive to second and third generation cephalosporins, Acinetobacter species, extended-spectrum β-lactamase (ESBL) Enterobacteriaceae such as Escherichia coli (E. coli) and Klebsiella pneumoniae (K. pneumoniae), Burkholderia cepacia (B. cepacia), Stenotrophomonas maltophilia (S. maltophilia), and methicillin resistant Staphylococcus aureus (MRSA).</description>
        <time_frame>seven days after admission</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PSI II</title>
            <description>PSI less than 70 or equal to 70</description>
          </group>
          <group group_id="O2">
            <title>PSI III</title>
            <description>PSI 70-90</description>
          </group>
          <group group_id="O3">
            <title>PSI IV</title>
            <description>PSI 90-130</description>
          </group>
          <group group_id="O4">
            <title>PSI V</title>
            <description>PSI more than 130</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With MDR Pathogens</title>
          <description>MDR bacteria were defined as Pseudomonas aeruginosa (P. aeruginosa), Enterobacter species, those not sensitive to second and third generation cephalosporins, Acinetobacter species, extended-spectrum β-lactamase (ESBL) Enterobacteriaceae such as Escherichia coli (E. coli) and Klebsiella pneumoniae (K. pneumoniae), Burkholderia cepacia (B. cepacia), Stenotrophomonas maltophilia (S. maltophilia), and methicillin resistant Staphylococcus aureus (MRSA).</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="51"/>
                <count group_id="O3" value="195"/>
                <count group_id="O4" value="269"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>MDR</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="72"/>
                    <measurement group_id="O4" value="120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mortality</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="24"/>
                    <measurement group_id="O4" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>The incidence of MDR pathogens (6.7%, 25.5%, 36.9% and 44.6% in PSI II, III, IV, and V, respectively, p=0.002) and mortality rate (0, 5.9%, 12.3%, and 23.8%, respectively, p&lt;0.001) increased with increasing PSI</groups_desc>
            <non_inferiority_type>Superiority or Other (legacy)</non_inferiority_type>
            <p_value>0.002</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>It was a retrospective observational study. No intervention was done during this study. Thereafter, no serious adverse event was assessed.</desc>
      <group_list>
        <group group_id="E1">
          <title>PSI II</title>
          <description>PSI less than 70 or equal to 70</description>
        </group>
        <group group_id="E2">
          <title>PSI III</title>
          <description>PSI 70-90</description>
        </group>
        <group group_id="E3">
          <title>PSI IV</title>
          <description>PSI 90-130</description>
        </group>
        <group group_id="E4">
          <title>PSI V</title>
          <description>PSI more than 130</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Serious adverse event</sub_title>
                <description>It was a retrospective observational study. No intervention was done during this study. Thereafter, no serious adverse event was assessed.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>non-serious adverse event</sub_title>
                <description>It was a retrospective observational study. No intervention was done during this study. Thereafter, no adverse event was assessed.</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The limitations to this study is that the microbiology data mainly came from sputum cultures, retrospective studies and single center experience</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Ping-huai Wang</name_or_title>
      <organization>Far Eastern Memorial hospital</organization>
      <phone>886-2-89667000 ext 2816</phone>
      <email>pinghuaiwang@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

